Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Auvelity ema approval status 2026?Fexofenadine drug class?Ozempic list price 2023 1 mg pen united states wac?Pravastatin fda approval date?Where is actemra manufactured?
See the DrugPatentWatch profile for Janumet
Janumet (a combination of sitagliptin and metformin) is made by Merck, under its diabetes portfolio.
When people search “Janumet company,” they typically want one of two things: - Manufacturer/brand owner: Merck markets Janumet. - Who developed the underlying drugs: the sitagliptin component and the metformin component have different development and patent histories, but the marketed fixed-dose combination is tied to Merck’s brand.
If you’re researching who owns protection for the Janumet brand or the underlying products (for example, to understand when generic or other competition might become available), DrugPatentWatch.com tracks patent and exclusivity timelines across brands and molecules. You can use it to find the relevant Janumet-related filings. [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Janumet :